Purpose The aim of this study was to investigate the association of anxiety and depression symptoms with health related quality of life (HRQoL) and sleep quality in patients with beta-thalassemia.
Introduction
Beta thalassemia is the commonest form of hemolytic anemia [1] , and every year approximately 60,000 thalassaemic babies are born worldwide [2] . With the availability of better transfusion regimen, iron chelation therapy, proper management of complications and good supportive care, it is now possible for a thalassemic patient to have a near normal life span with a good health related quality of life (HRQoL) [1] . As a result, attention has shifted to the well being of the patients with thalassemia [3] .
A high rate of psychological distress has been reported in patients with thalassemia in different surveys. Depressive moods and anxiety were diagnosed in children with thalassemia major in a study conducted in Italy [4] . Same results were found in a similar study conducted in Singapore [5] . It is also observed that subjects with chronic illness limiting their daily life, experience more depression than those without limiting daily life [6] . Another study conducted in Utrecht, Netherlands [7] points to the depressive coping styles in thalassemic adolescents. But in India, such a study is a lay felt.
Anxiety and depression have been shown to decrease well being [8, 9] . Previous studies in patients with thalassemia, however, have mainly focused on the HRQOL [10] , few data exists on the impact of these symptoms on HRQoL [10], and we did not any study regarding their impact on sleep quality of these patients.
Considering the lack of data about the impact of anxiety and depression on the wellbeing of adult patients with beta thalassemia, we designed this study to investigate the association between these psychological symptoms and HRQoL and sleep quality perceived by this population.
Method and material
In a cross-sectional study between 2006 and 2007, 320 adult patients with beta thalassemia were invited to participate in our study, from whom, 292 (91.2%) agreed to participate. The subjects were selected through a census sampling method. The study was approved by the Ethics Committee of the Blood Transfusion Research Center, Tehran, Iran, and informed consent was obtained from all the participants. The inclusion criteria for subjects were stable clinical condition and absence of any acute concomitant disease or infection.
Independent variables

Anxiety and depression
Symptoms of anxiety and depression were assessed using the translated version of Hospital Anxiety Depression Scale (HADS). HADS was previously validated for the Iranian population [11] . The HADS contains 14 items and two subscales: anxiety and depression. Each item is scored from 0 to 3, giving maximal scores of 21 for anxiety and depression [12] . Scores of >=11 on either subscale are considered a signifi cant case of psychological morbidity (clinical caseness) [13] .
Somatic comorbidities
Somatic comorbidities were assessed by using Ifudu score. The Ifudu comorbidity scale is a numerical index for monitoring the patients with chronic illnesses and assessing the medical comorbidity. The authors originally evaluated 13 major organ systems. The diseases evaluated included ischemic heart diseases, other cardiovascular problems (such as hypertension, congestive heart failure, cardiomyopathy, other nonischemic diseases), respiratory diseases, autonomic neuropathy (gastroparesis, obstipation, diarrhea, cystopathy, and orthostatic hypotension), neurological problems, cerebrovascular accidents or residual stroke, AIDS, infections in liver, pancreas, gallbladder (excluding the infection of the vascular access site or peritonitis), hematologic problems (excluding anemia), spinal abnormalities, low back problems or arthritis, vision impairment (decreased visual acuity to blindness), limb amputation, and genitourinary diseases. Each item is scored from 0 to 3. Total comorbidity index was calculated with SUM points for all 12 organ systems, after deleting item related to hematologic diseases. As a result, range of the scores was between 0 and 36. The higher was the index, the greater was the comorbidity [14] .
Dependent variable
The checklist contained questions about the demographic data (age, gender, marital status, living place, and educational status), weight, height, and thalassemia related data (medications, thalassemia type, duration of disease, HCV). We also used scales of quality of life 
